UiPath Inc. (PATH) Stock Forecast
PATH analyst forecast
as of October 18, 2026- Analyst consensus
- Hold 3.14 / 5 from 21 analysts
- Price target
- $15.50 average of analyst targets
- Upside to target
- +20.6% from the latest close
- Next earnings
- December 2, 2026 EPS estimate $0.10
- 52-week range
- $9.38 – $19.29
PATH analyst ratings
21 analystsNumber of analysts at each rating.
PATH price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
PATH earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Oct '26) | $0.19 | $0.16 | $0.22 | $0.16 | +19.4% | 20 |
| Current fiscal year (FY2027) | $0.79 | $0.71 | $0.86 | $0.72 | +9.3% | 22 |
| Next fiscal year (FY2028) | $0.92 | $0.75 | $1.11 | $0.79 | +17.0% | 22 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
PATH revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Oct '26) | $443.0M | $442.4M | $444.5M | +7.8% | 18 |
| Current fiscal year (FY2027) | $1.79B | $1.79B | $1.80B | +11.3% | 20 |
| Next fiscal year (FY2028) | $1.94B | $1.91B | $1.98B | +8.4% | 21 |
PATH EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
PATH revenue: reported and forecast
PATH EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Oct '26) | $0.19 | $0.19 | $0.19 | $0.19 | $0.19 | +2.2% | 7 up · 5 down |
| Current fiscal year (FY2027) | $0.79 | $0.79 | $0.78 | $0.79 | $0.79 | +0.2% | 9 up · 5 down |
| Next fiscal year (FY2028) | $0.91 | $0.91 | $0.91 | $0.92 | $0.92 | +1.5% | 13 up · 7 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
PATH earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; PATH beat in 12 of 12.
What analysts expect from PATH
21 analysts cover UiPath; their consensus rating is hold (3.14 on a 1–5 scale, where 5 is a strong buy). The average price target is $15.50, 20.6% above the latest close of $12.85. Analysts expect earnings of $0.79 per share for FY2027, +9.3% from a year earlier. For FY2028 the average estimate is $0.92 per share on revenue of $1.9 billion. UiPath beat the EPS estimate in 12 of the last 12 quarters.
Related: PATH income statement, PATH key metrics, PATH chart. See the PATH stock overview for the latest quote and news.
PATH forecast FAQ
What is UiPath's price target?
The average analyst price target for UiPath is $15.50, 20.6% above the latest close of $12.85.
Is UiPath a buy, hold or sell?
Of 21 analysts covering UiPath, 2 rate it a strong buy, 1 a buy, 16 a hold, 2 a sell and 0 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.
What is UiPath's EPS forecast?
Analysts forecast $0.79 per share for FY2027 (range $0.71 to $0.86); for FY2028 the estimate is $0.92.
What is UiPath's revenue forecast?
The average revenue estimate for FY2027 is $1.8 billion, growth of 11.3%; for FY2028 it is $1.9 billion.
When does UiPath report earnings?
UiPath is expected to report results for the quarter ending October 31, 2026 on December 2, 2026 after the market closes; the EPS estimate is $0.10.
Does UiPath usually beat earnings estimates?
UiPath reported EPS at or above the analyst estimate in 12 of the last 12 quarters.